Prism Pharmaceuticals

Acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products.

Launch date

Jan 2003

Employees

Market cap

Enterprise valuation

Lincoln Nebraska (HQ)

Date	Investors	Amount	Round
Aug 2005	N/A	N/A	Series A
Sep 2006	Essex Woodlands Health Ventures EW Healthcare Partners	$15.0m	Series B
Jan 2007	Stephens Group	N/A	-
Apr 2011	Baxter International	$338m Valuation: $338m	Acquisition
Jun 2013	INCJ	$15.0m	Series C
Total Funding		€27.3m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Prism Pharmaceuticals